{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:43:47Z","timestamp":1789613027599,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bone.2017.11.015","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T11:16:17Z","timestamp":1511349377000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Sclerostin deficiency modifies the development of CKD-MBD in mice"],"prefix":"10.1016","volume":"107","author":[{"given":"Nadine","family":"Kaesler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"De Mar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Deck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J.","family":"Behets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayshe","family":"Hyusein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Babler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kneissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Kramann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"D'Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.11.015_bb0005","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2017.11.015_bb0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","article-title":"The role of wnt signaling in physiological and pathological angiogenesis","volume":"107","author":"Dejana","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2017.11.015_bb0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0b013e32816e06f9","article-title":"The Wnt signaling pathway and bone metabolism","volume":"19","author":"Johnson","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2017.11.015_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2017.11.015_bb0025","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.11.015_bb0030","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2017.11.015_bb0035","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/ndt\/gfr591","article-title":"The connections between vascular calcification and bone health","volume":"26","author":"Cannata-Andia","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bone.2017.11.015_bb0040","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2017.11.015_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.11.015_bb0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tem.2012.06.001","article-title":"Wnt signaling in cardiovascular physiology","volume":"23","author":"Marinou","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.11.015_bb0055","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","article-title":"LRP6 mutation in a family with early coronary disease and metabolic risk factors","volume":"315","author":"Mani","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.11.015_bb0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2017.11.015_bb0065","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2017.11.015_bb0070","first-page":"2618","article-title":"Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation","volume":"33","author":"Kaesler","year":"2014","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bone.2017.11.015_bb0075","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2017.11.015_bb0080","series-title":"Lanthanum Carbonate and Bone","author":"Behets","year":"2005"},{"issue":"5","key":"10.1016\/j.bone.2017.11.015_bb0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40620-017-0424-8","article-title":"Update on the role of bone biopsy in the management of patients with CKD-MBD","volume":"30","author":"Evenepoel","year":"2017","journal-title":"J. Nephrol."},{"issue":"1","key":"10.1016\/j.bone.2017.11.015_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.11.015_bb0095","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass","volume":"21","author":"Morvan","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.11.015_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00774-010-0202-3","article-title":"Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice","volume":"29","author":"Yao","year":"2011","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.bone.2017.11.015_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-015-3069-7","article-title":"From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD","volume":"31","author":"Brandenburg","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"17","key":"10.1016\/j.bone.2017.11.015_bb0110","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJMc1402396","article-title":"Romosozumab in postmenopausal women with osteopenia","volume":"370","author":"Evenepoel","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2017.11.015_bb0115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.kint.2016.06.019","article-title":"Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease","volume":"90","author":"Cejka","year":"2016","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.bone.2017.11.015_bb0120","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3109\/0886022X.2015.1077323","article-title":"Effect of SOST gene deletion on the progression of renal interstitial fibrosis in obstructive kidney injury","volume":"37","author":"Wang","year":"2015","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.bone.2017.11.015_bb0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jcb.22607","article-title":"Runx2\/Cbfa1, but not loss of myocardin is required for smooth muscle cell lineage reprogramming towards osteochondrogenesis","volume":"110","author":"Speer","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.bone.2017.11.015_bb0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"11","author":"Schafer","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.11.015_bb0135","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1681\/ASN.2009040409","article-title":"Vascular calcification: the three-hit model","volume":"20","author":"Moe","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.11.015_bb0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2012.09.016","article-title":"Effects of PTH on osteocyte function","volume":"54","author":"Bellido","year":"2013","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2017.11.015_bb0145","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol. Cell. Biol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T10:12:04Z","timestamp":1539166324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217304362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"alternative-id":["S8756328217304362"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.11.015","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerostin deficiency modifies the development of CKD-MBD in mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}